You are more than welcome to contact us

Pharmaceutical companies or investors interested in learning more and partnering with OncoZenge to bring BupiZenge to market, get in touch:

Get in touch


For general inquiries contact us at


For media or investor queries please contact our CEO Stian Kildal

Visiting & mailing adress

Gustavslundsvägen 34 167 51 Stockholm, Sweden

Subscribe to our newsletter!

Sign up today and receive company updates straight to your inbox.


Join our journey! Sign up and get our latest news and reports.